期 |
栏目 |
标题 |
文件 |
卷 17, 编号 2 (2020) |
Original studies |
Seasonal allergic rhinitis and its control with antihistamines in an outpatient practice. |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 18, 编号 4 (2021) |
Clinical practice guidelines |
Asthma |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Atopic dermatitis |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Vaccination of patients with allergic disease against novel coronavirus infection: position paper of the Russian Association of Allergology and Clinical Immunology |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 19, 编号 1 (2022) |
Clinical practice guidelines |
Allergic rhinitis |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 19, 编号 2 (2022) |
Clinical practice guidelines |
Practical issues in the use of emollients containing filaggrin modulators in the management of patients with atopic dermatitis and xerosis: Resolution of the Expert board |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 18, 编号 2 (2021) |
Help to the practitioner |
Hereditary angioedema. Clinical guidelines. (D84.1) |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 19, 编号 3 (2022) |
Clinical practice guidelines |
The use of Cetirizine and Levocetirizine in patients with chronic urticaria and other allergic dermatoses: issues of dosage increasing and long-term use. Resolution of the Advisory Board |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 20, 编号 2 (2023) |
Reviews |
Is Quifenadine an antihistamine of the first generation? Do we know everything… |
|
卷 20, 编号 2 (2023) |
Case reports |
How to fit an antihistamine, taking into account the individual characteristics of the patient: From pharmacokinetics to profiling |
|